p53 and p73 expression in esophageal carcinoma correlate with clinicopathology of tumors

Hepato-Gastroenterology

Volumn 59, Issue 119, 2012, Pages 2192-2195

  Ye, Bing ^a   Wang, Xuefeng ^b   Yang, Zhenzhong ^a   Sun, Zhengping ^a   Zhang, Rongbo ^b   Hu, Youying ^b   Lu, Youguo ^a   Du, Jiuwei ^b  

^a Xinhua Hospital of Huainan City   (China)

^b ANHUI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Clinicopathological parameter; Esophageal cancer; Immunohistochemistry; p53; p73

Indexed keywords

PROTEIN P53; PROTEIN P73;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INFILTRATION; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

ADULT; AGED; CARCINOMA; CELL DIFFERENTIATION; CHI-SQUARE DISTRIBUTION; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84868591829     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11964     Document Type: Article

References (13)

1. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010; 60(5):277-300.
2. Oren M, Rotter V: Mutant p53 gain-of-ranction in cancer. Cold Spring Harb Perspect Biol 2010; 2:a001107.
3. Machado-Silva A, Perrier S, Bourdon JC: p53 family members in cancer diagnosis and treatment. Semin Cancer Biol 2010; 20(1):57-62.
4. Marabese M, Vikhanskaya F, Broggini M: p73: a chiaroscuro gene in cancer. Eur J Cancer 2007; 43(9):1361-1372.
5. Vazquez A, Bond EE, Levine AJ, Bond GL: The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 2008; 7(12):979-987.
6. Chari NS, Pinaire NL, Thorpe L, et al.: The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death. Apoptosis 2009; 14(4):336-347.
7. Janssen KP, el-Marjou F, Pinto D, et al.: Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. Gastroenterology 2002; 123(2):492-504.
8. Hageman GJ, Stierum RH: Niacin, poly(ADP-ribose) polymerase-1 and genomic stability. Mutat Res 2001; 475(1-2):45-56.
9. Shi ST, Yang GY, Wang LD, et al.: Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions. Carcinogenesis 1999; 20(4):591-597.
10. Lee EY, Muller WJ: Oncogenes and tumor suppressor genes. Cold Spring Harb Perspect Biol 2010; 2(10):a003236.
11. Doak SH, Jenkins GJ, Parry EM, et al: Characterization of p53 status at the gene, chromosomal and protein levels in esophageal adenocarcinoma. Br J Cancer 2003; 89(9):1729-1735.
12. Mai M, Yokomizo A, Qian C, et al.: Activation of p73 silent allele in lung cancer. Cancer Res 1998; 58(11):2347-2349.
13. Vilgelm AE, Hong SM, Washington MK, et al.: Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors. Oncogene 2010; 29(43):5861-5868.